Drug intelligence / Profile preview

cefixime + ofloxacin (Helax Healthcare)

Development stage
Unknown
Lead developer
Helax Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Cefwell-O is a fixed-dose combination antibiotic product marketed by Helax Healthcare, typically containing cefixime and ofloxacin. Cefixime is a third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis. Ofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. This combination is used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and typhoid fever, providing a broader spectrum of activity against both Gram-positive and Gram-negative pathogens.

Brand names
Cefwell-O
Other names
Cefixime and Ofloxacin Tablets
02

Targets

PBP (Penicillin-binding protein family)Topo IV (Bacterial Topoisomerase IV)DNA gyrase

Beyond the preview

Go deeper on cefixime + ofloxacin (Helax Healthcare).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefixime + ofloxacin (Helax Healthcare).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call